Brevet Année : 2022

URINARY BRANCHED-CHAIN AMINO ACIDS (UBCAAS) AS INSULIN RESISTANCE BIOMARKERS

Résumé

The present invention is directed to method of determining whether a subject is at risk of developing insulin resistance, particularly for advance alert of T2D and or CVD onset in obese and non-obese subject, by detecting the branched-chain amino acids (BCAAs) present in an urine sample (uBCAAs) of the subjects. The present invention also relates to a method for determining the need of a dietary/nutritional supplement for a subject involving said uBCAAs biomarkers. Finally, the invention is directed to kit comprising the biochemical network allowing the uBCAAs detection and process for the preparation of said biochemical networks as diagnostic biomarker.
Fichier non déposé

Dates et versions

hal-04883907 , version 1 (13-01-2025)

Identifiants

  • HAL Id : hal-04883907 , version 1

Citer

Francisco Santos Schneider, Franck Molina, Eric Renard. URINARY BRANCHED-CHAIN AMINO ACIDS (UBCAAS) AS INSULIN RESISTANCE BIOMARKERS. France, Patent n° : WO2023/233017A1. 2022. ⟨hal-04883907⟩
0 Consultations
0 Téléchargements

Partager

More